Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 18.32
-0.64 (-3.38%)
Jul 10, 2026, 3:04 PM CST
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 9.87 billion as of July 10, 2026. Its market cap has increased by 98.27% in one year.
Market Cap
9.87B
Enterprise Value
11.03B
Revenue
1.31B
Ranking
n/a
PE Ratio
2,510.21
Stock Price
18.32
Market Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 9.87B, an increase of 520.73%. That is a compound annual growth rate of 18.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 9.87B | 21.24% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 11.42B |
| Tibet Cheezheng Tibetan Medicine | 11.36B |
| Beijing Hotgen Biotech | 10.94B |
| Chengzhi | 10.63B |
| GemPharmatech | 10.41B |
| Hualan Biological Vaccine | 10.06B |
| Chengdu Easton Biopharmaceuticals | 9.74B |
| Nanjing Vazyme Biotech | 9.34B |